These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 35960749)

  • 21. S100A9 promotes tumor-associated macrophage for M2 macrophage polarization to drive human liver cancer progression: An in vitro study.
    Yang LF; Zhang ZB; Wang L
    Kaohsiung J Med Sci; 2023 Apr; 39(4):345-353. PubMed ID: 36807724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Honokiol prevents lung metastasis of triple-negative breast cancer by regulating polarization and recruitment of macrophages.
    Mei M; Tang L; Zhou H; Xue N; Li M
    Eur J Pharmacol; 2023 Nov; 959():176076. PubMed ID: 37797675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer.
    Zhang R; Shen Y; Zhang Q; Feng X; Liu X; Huo X; Sun J; Hao J
    Cell Death Dis; 2023 Dec; 14(12):850. PubMed ID: 38123542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer.
    Ramos Solis N; Cannon A; Dilday T; Abt M; Oblak AL; Soloff AC; Kaplan MH; Yeh ES
    Oncoimmunology; 2024; 13(1):2364382. PubMed ID: 38846083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 26. OTUD5-mediated deubiquitination of YAP in macrophage promotes M2 phenotype polarization and favors triple-negative breast cancer progression.
    Zhang Y; Fan Y; Jing X; Zhao L; Liu T; Wang L; Zhang L; Gu S; Zhao X; Teng Y
    Cancer Lett; 2021 Apr; 504():104-115. PubMed ID: 33587979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
    Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
    J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein-Bound Polysaccharides from
    Jędrzejewski T; Pawlikowska M; Sobocińska J; Wrotek S
    Cell Physiol Biochem; 2020 Jun; 54(4):615-628. PubMed ID: 32559360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MIF as a potential diagnostic and prognostic biomarker for triple-negative breast cancer that correlates with the polarization of M2 macrophages.
    Chen M; Liu H; Hong B; Xiao Y; Qian Y
    FASEB J; 2024 May; 38(10):e23696. PubMed ID: 38787620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Integrative Analysis Reveals the Association of
    Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human breast cancer cells educate macrophages toward the M2 activation status.
    Sousa S; Brion R; Lintunen M; Kronqvist P; Sandholm J; Mönkkönen J; Kellokumpu-Lehtinen PL; Lauttia S; Tynninen O; Joensuu H; Heymann D; Määttä JA
    Breast Cancer Res; 2015 Aug; 17(1):101. PubMed ID: 26243145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
    Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
    J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α.
    Zhou H; Gan M; Jin X; Dai M; Wang Y; Lei Y; Lin Z; Ming J
    Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36069230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
    Cao X; Li B; Chen J; Dang J; Chen S; Gunes EG; Xu B; Tian L; Muend S; Raoof M; Querfeld C; Yu J; Rosen ST; Wang Y; Feng M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophages confer resistance to BET inhibition in triple-negative breast cancer by upregulating IKBKE.
    Qiao J; Chen Y; Mi Y; Jin H; Wang L; Huang T; Li H; Song Y; Cao J; Wu B; Wang Q; Zou Z
    Biochem Pharmacol; 2020 Oct; 180():114126. PubMed ID: 32603665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL9 influences the tumor immune microenvironment by stimulating JAK/STAT pathway in triple-negative breast cancer.
    Wu L; Sun S; Qu F; Sun M; Liu X; Sun Q; Cheng L; Zheng Y; Su G
    Cancer Immunol Immunother; 2023 Jun; 72(6):1479-1492. PubMed ID: 36472587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with
    Bouchard A; Sikner H; Baverel V; Garnier AR; Monterrat M; Moreau M; Limagne E; Garrido C; Kohli E; Collin B; Bellaye PS
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.
    Kim S; Choi I; Han IH; Bae H
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage.
    Meng Z; Zhang R; Wang Y; Zhu G; Jin T; Li C; Zhang S
    Int Immunopharmacol; 2020 Apr; 81():106028. PubMed ID: 31801690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization.
    Leonard F; Curtis LT; Hamed AR; Zhang C; Chau E; Sieving D; Godin B; Frieboes HB
    Cancer Immunol Immunother; 2020 May; 69(5):731-744. PubMed ID: 32036448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.